EUVIMEDEUVIMED entdecken
Crossref

Utility of CCR7 to differentiate classic Hodgkin lymphoma and other B-cell lymphomas by flow cytometry and immunohistochemistry

Xueyan Chen, Lori Soma, Claire Murphy, Maria Tretiakova, Kikkeri N Naresh iD, Jonathan R Fromm

American Journal of Clinical Pathology · 2025

DOI: 10.1093/ajcp/aqae119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2025. Verfasst von Xueyan Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, US. Hauptthemen laut MEDLINE: Receptors, CCR7, Hodgkin Disease, Biomarkers, Tumor, Lymphoma, B-Cell. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Classic Hodgkin lymphoma (CHL) is characterized by infrequent neoplastic Hodgkin and Reed-Sternberg (HRS) cells in an inflammatory background. The diagnostic utility of CC-chemokine receptor 7 (CCR7) in CHL was explored using flow cytometry and immunohistochemistry (IHC).

Methods

Neoplastic specimens and non-neoplastic lymph nodes were immunophenotyped and CCR7 expression was measured semiquantitatively by flow cytometry (clone 3D12) and IHC (clone 150503).

Results

Our results showed that CCR7 was expressed on HRS cells in the vast majority of CHL cases (45/48 by flow cytometry, 57/59 by IHC) but rarely expressed in neoplastic cells in diffuse large B-cell lymphoma, not otherwise specified (1/25 by flow cytometry, 2/40 by IHC) and nodular lymphocyte predominant Hodgkin lymphoma (0/4 by flow cytometry, 1/13 by IHC). Primary mediastinal large B-cell lymphoma (PMLBCL) revealed weak CCR7 expression by flow cytometry in most cases (8/10) but only occasionally by IHC (2/12). Both cases (2/2) of T-cell/histiocyte-rich large B-cell lymphoma (THRLBCL) also showed CCR7 expression detected by flow cytometry compared with IHC (0/7). The HRS cells demonstrated a greater percentage of positive cells and greater antigen intensity than the other B-cell lymphomas by IHC. The expression identified by flow cytometry in PMLBCL and THRLBCL but not by IHC suggests that there may be differences in the detection capabilities of the 2 techniques or the 2 CCR7 clones used.

Conclusions

The expression of CCR7 in HRS cells suggests its potential utility in differentiating CHL from other B-cell lymphomas. Incorporating CCR7 into flow cytometry and IHC panels may further enhance the diagnostic sensitivity of CHL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, CCR7Hodgkin DiseaseBiomarkers, TumorLymphoma, B-CellHumansImmunohistochemistryFlow CytometryDiagnosis, DifferentialMiddle AgedMaleFemaleAgedReed-Sternberg CellsAdultImmunophenotypingAged, 80 and overLymphoma, Large B-Cell, DiffuseLymph NodesYoung AdultAdolescent

Stichwörter der Autor:innen

CCR7T-cell/histiocyte-rich large B-cell lymphomaantigen expressionclassic Hodgkin lymphomadiffuse large B-cell lymphomaflow cytometryimmunohistochemistrynodular lymphocyte predominant Hodgkin lymphomaprimary mediastinal large B-cell lymphoma“grey zone” lymphoma

Substanzen

Receptors, CCR7CCR7 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, US.
  • Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, US.
  • Department of Pathology, City of Hope, Duarte, CA, US.
  • Pathology Consultants, PC, Eugene/Springfield Lab, Springfield, OR, US.

ORCID-Profile: Kikkeri N Naresh

Zitieren

APA

Chen, X., Soma, L., Murphy, C., Tretiakova, M., Naresh, K. N., & Fromm, J. R. (2025). Utility of CCR7 to differentiate classic Hodgkin lymphoma and other B-cell lymphomas by flow cytometry and immunohistochemistry. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqae119

Vancouver

Chen X, Soma L, Murphy C, Tretiakova M, Naresh KN, Fromm JR. Utility of CCR7 to differentiate classic Hodgkin lymphoma and other B-cell lymphomas by flow cytometry and immunohistochemistry. American Journal of Clinical Pathology. 2025. doi:10.1093/ajcp/aqae119

BibTeX
@article{Chen2025,
  author = {Chen, Xueyan and Soma, Lori and Murphy, Claire and Tretiakova, Maria and Naresh, Kikkeri N and Fromm, Jonathan R},
  title = {Utility of CCR7 to differentiate classic Hodgkin lymphoma and other B-cell lymphomas by flow cytometry and immunohistochemistry},
  journal = {American Journal of Clinical Pathology},
  year = {2025},
  doi = {10.1093/ajcp/aqae119}
}
Kostenlos starten →